Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence

NCT02447016 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT02447016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2015
Completion date
December 21, 2016
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv